{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:20:07Z","timestamp":1773249607477,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jlr.2022.100179","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T11:16:57Z","timestamp":1644491817000},"page":"100179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2396-5385","authenticated-orcid":false,"given":"Sophia M.","family":"Sears","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tess V.","family":"Dupre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parag P.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deanna L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Doll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cierra N.","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9359-6880","authenticated-orcid":false,"given":"Alexis A.","family":"Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Megyesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levi J.","family":"Beverly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley J.","family":"Snider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina M.","family":"Obeid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf A.","family":"Hannun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5026-5187","authenticated-orcid":false,"given":"Leah J.","family":"Siskind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2022.100179_bib1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jlr.2022.100179_bib2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2478\/raon-2019-0018","article-title":"Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy","volume":"53","author":"Makovec","year":"2019","journal-title":"Radiol. Oncol."},{"key":"10.1016\/j.jlr.2022.100179_bib3","doi-asserted-by":"crossref","first-page":"102925","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: the first metal based anticancer drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jlr.2022.100179_bib4","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.jlr.2022.100179_bib5","doi-asserted-by":"crossref","first-page":"967826","DOI":"10.1155\/2014\/967826","article-title":"Pathophysiology of cisplatin-induced acute kidney injury","volume":"2014","author":"Ozkok","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jlr.2022.100179_bib6","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.jlr.2022.100179_bib7","series-title":"Comprehensive Toxicology","first-page":"452","article-title":"14.19 - Renal toxicology\/nephrotoxicity of cisplatin and other chemotherapeutic agents","author":"Dupre","year":"2018"},{"key":"10.1016\/j.jlr.2022.100179_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/sdi.12705","article-title":"Acute kidney injury: epidemiology, outcomes, complications, and therapeutic strategies","volume":"31","author":"Negi","year":"2018","journal-title":"Semin. Dial."},{"key":"10.1016\/j.jlr.2022.100179_bib9","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/j.2040-4603.2012.tb00431.x","article-title":"Pathophysiology of acute kidney injury","volume":"2","author":"Basile","year":"2012","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.jlr.2022.100179_bib10","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1016\/j.ejca.2009.06.032","article-title":"Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors","volume":"45","author":"Skinner","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jlr.2022.100179_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.semnephrol.2020.01.011","article-title":"Pathophysiology of AKI to CKD progression","volume":"40","author":"Sato","year":"2020","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.jlr.2022.100179_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1681\/ASN.2020050697","article-title":"Sphingosine-1-phosphate metabolism and signaling in kidney diseases","volume":"32","author":"Drexler","year":"2021","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jlr.2022.100179_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jbior.2018.11.003","article-title":"The role of sphingolipids is acute kidney injury","volume":"70","author":"Dupre","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jlr.2022.100179_bib14","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.3390\/ijms18122528","article-title":"Translational aspects of sphingolipid metabolism in renal disorders","volume":"18","author":"Abou Daher","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jlr.2022.100179_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jlr.2022.100179_bib16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jlr.2022.100179_bib17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbalip.2008.06.002","article-title":"Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate","volume":"1781","author":"Mao","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jlr.2022.100179_bib18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jbior.2016.10.002","article-title":"Ceramidases, roles in sphingolipid metabolism and in health and disease","volume":"63","author":"Coant","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jlr.2022.100179_bib19","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.str.2015.07.003","article-title":"Catalytic mechanism of eukaryotic neutral ceramidase","volume":"23","author":"Malinina","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.jlr.2022.100179_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jbior.2018.10.005","article-title":"Neutral ceramidase: advances in mechanisms, cell regulation, and roles in cancer","volume":"71","author":"Coant","year":"2019","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jlr.2022.100179_bib21","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1194\/jlr.M076745","article-title":"Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury","volume":"58","author":"Dupre","year":"2017","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2022.100179_bib22","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1042\/BJ20150586","article-title":"Loss of neutral ceramidase protects cells from nutrient- and energy -deprivation-induced cell death","volume":"473","author":"Sundaram","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.jlr.2022.100179_bib23","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/ki.2012.261","article-title":"Autophagy in proximal tubules protects against acute kidney injury","volume":"82","author":"Jiang","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.jlr.2022.100179_bib24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ajpath.2011.11.001","article-title":"Autophagy guards against cisplatin-induced acute kidney injury","volume":"180","author":"Takahashi","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jlr.2022.100179_bib25","doi-asserted-by":"crossref","first-page":"13142","DOI":"10.1074\/jbc.M113.530311","article-title":"Essential roles of neutral ceramidase and sphingosine in mitochondrial dysfunction due to traumatic brain injury","volume":"289","author":"Novgorodov","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100179_bib26","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1074\/jbc.M508382200","article-title":"Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids","volume":"281","author":"Kono","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100179_bib27","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1096\/fj.201600611R","article-title":"Role of neutral ceramidase in colon cancer","volume":"30","author":"Garc\u00eda-Barros","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.jlr.2022.100179_bib28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41419-020-2655-1","article-title":"The circadian clock gene Bmal1 facilitates cisplatin-induced renal injury and hepatization","volume":"11","author":"Zha","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jlr.2022.100179_bib29","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bbrc.2018.05.056","article-title":"Effect of cisplatin on the clock genes expression in the liver, heart and kidney","volume":"501","author":"Cao","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jlr.2022.100179_bib30","doi-asserted-by":"crossref","first-page":"F674","DOI":"10.1152\/ajprenal.00196.2020","article-title":"C57BL\/6 mice require a higher dose of cisplatin to induce renal fibrosis and CCL2 correlates with cisplatin-induced kidney injury","volume":"319","author":"Sears","year":"2020","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.jlr.2022.100179_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1124\/jpet.111.190249","article-title":"Recovery from glycerol-induced acute kidney injury is accelerated by suramin","volume":"341","author":"Korrapati","year":"2012","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jlr.2022.100179_bib32","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.toxlet.2013.11.014","article-title":"Suppressed mitochondrial biogenesis in folic acid-induced acute kidney injury and early fibrosis","volume":"224","author":"Stallons","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jlr.2022.100179_bib33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0022-3565(25)32105-1","article-title":"Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations","volume":"213","author":"Dobyan","year":"1980","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jlr.2022.100179_bib34","doi-asserted-by":"crossref","first-page":"9100","DOI":"10.1074\/jbc.M210284200","article-title":"Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling","volume":"278","author":"Mandic","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100179_bib35","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","article-title":"Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion","volume":"14","author":"Mauthe","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.jlr.2022.100179_bib36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jlr.2022.100179_bib37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0006-2952(93)90391-9","article-title":"Chloroquine stabilization of phospholipid membranes against diacylglycerol-induced perturbation","volume":"45","author":"Zidovetzki","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jlr.2022.100179_bib38","doi-asserted-by":"crossref","first-page":"11818","DOI":"10.1074\/jbc.M109.078121","article-title":"The BCL-2 protein BAK is required for long-chain ceramide generation during apoptosis","volume":"285","author":"Siskind","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100179_bib39","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/cdd.2014.128","article-title":"Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling","volume":"22","author":"Yabu","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jlr.2022.100179_bib40","doi-asserted-by":"crossref","first-page":"8970","DOI":"10.1073\/pnas.92.19.8970","article-title":"Sphingosine: a mediator of acute renal tubular injury and subsequent cytoresistance","volume":"92","author":"Iwata","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2022.100179_bib41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.prostaglandins.2012.08.003","article-title":"Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease","volume":"99","author":"Snider","year":"2012","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.jlr.2022.100179_bib42","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1681\/ASN.2013121351","article-title":"Sphingosine 1-phosphate receptor-1 enhances mitochondrial function and reduces cisplatin-induced tubule injury","volume":"26","author":"Bajwa","year":"2015","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jlr.2022.100179_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ddmec.2007.07.001","article-title":"Targeting sphingosine 1 phosphate receptor type 1 receptors in acute kidney injury","volume":"4","author":"Okusa","year":"2007","journal-title":"Drug Discov. Today Dis. Mech."},{"key":"10.1016\/j.jlr.2022.100179_bib44","doi-asserted-by":"crossref","first-page":"F1516","DOI":"10.1152\/ajprenal.00311.2005","article-title":"Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney","volume":"290","author":"Awad","year":"2006","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.jlr.2022.100179_bib45","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1681\/ASN.2015080922","article-title":"Endothelial sphingosine-1 phosphate receptor-1 mediates protection and recovery from acute kidney injury","volume":"27","author":"Perry","year":"2016","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jlr.2022.100179_bib46","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1681\/ASN.2009060662","article-title":"Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury","volume":"21","author":"Bajwa","year":"2010","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jlr.2022.100179_bib47","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1681\/ASN.2015010095","article-title":"Sphingosine 1-phosphate receptor 3-deficient dendritic cells modulate splenic responses to ischemia-reperfusion injury","volume":"27","author":"Bajwa","year":"2016","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jlr.2022.100179_bib48","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.4049\/jimmunol.1200999","article-title":"Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury","volume":"189","author":"Bajwa","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jlr.2022.100179_bib49","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s10495-015-1108-2","article-title":"Autophagy in the light of sphingolipid metabolism","volume":"20","author":"Harvald","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.jlr.2022.100179_bib50","doi-asserted-by":"crossref","first-page":"17402","DOI":"10.1073\/pnas.0802781105","article-title":"Ceramide starves cells to death by downregulating nutrient transporter proteins","volume":"105","author":"Guenther","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2022.100179_bib51","doi-asserted-by":"crossref","first-page":"18384","DOI":"10.1074\/jbc.M313561200","article-title":"Ceramide-mediated macroautophagy involves inhibition of protein kinase B and up-regulation of beclin 1","volume":"279","author":"Scarlatti","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100179_bib52","doi-asserted-by":"crossref","first-page":"8518","DOI":"10.1074\/jbc.M506182200","article-title":"Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation","volume":"281","author":"Lavieu","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100179_bib53","doi-asserted-by":"crossref","first-page":"C451","DOI":"10.1152\/ajpcell.00586.2008","article-title":"S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells","volume":"297","author":"Chang","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.jlr.2022.100179_bib54","doi-asserted-by":"crossref","first-page":"F161","DOI":"10.1152\/ajprenal.00636.2017","article-title":"Subclinical kidney injury induced by repeated cisplatin administration results in progressive chronic kidney disease","volume":"315","author":"Sharp","year":"2018","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.jlr.2022.100179_bib55","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1681\/ASN.2020101455","article-title":"Potential therapeutic targets for cisplatin-induced kidney injury: lessons from other models of AKI and fibrosis","volume":"32","author":"Sears","year":"2021","journal-title":"J.\u00a0Am. Soc. Nephrol."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227522000128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227522000128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T18:31:06Z","timestamp":1758306666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227522000128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0022227522000128"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2022.100179","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2022.100179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100179"}}